Terms: = Colorectal cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53
6943 results:
1. Genetic polymorphisms in FABP2, CYP2E1, and tp53 genes are potentially associated with colorectal cancer susceptibility.
Ijaz M; Chen CC; Iqbal RK; Farooq HA; Mehmood R; Asif M; Akbar A; Khan A; Ijaz W; Said MB; Wondmie GF; Ibenmoussa S; Okla MK; Iqbal F
Sci Rep; 2024 Sep; 14(1):20464. PubMed ID: 39242607
[TBL] [Abstract] [Full Text] [Related]
2. NLRC4, inflammation and colorectal cancer (Review).
Tong G; Shen Y; Li H; Qian H; Tan Z
Int J Oncol; 2024 Oct; 65(4):. PubMed ID: 39239759
[TBL] [Abstract] [Full Text] [Related]
3. Green synthesis of copper oxide nanoparticles using walnut shell and their size dependent anticancer effects on breast and colorectal cancer cell lines.
Abdollahzadeh H; Pazhang Y; Zamani A; Sharafi Y
Sci Rep; 2024 Sep; 14(1):20323. PubMed ID: 39223184
[TBL] [Abstract] [Full Text] [Related]
4. Genomic profiling of colorectal cancer in large-scale Chinese patients: amplification and somatic mutations in ERBB2.
Liu Y; Bischof E; Chen Z; Zhou J; Zhang B; Zhang D; Gao Y; Quan M
Oncol Res; 2024; 32(9):1429-1438. PubMed ID: 39220126
[TBL] [Abstract] [Full Text] [Related]
5. p53 Orchestrates cancer Metabolism: Unveiling Strategies to Reverse the Warburg Effect.
Abukwaik R; Vera-Siguenza E; Tennant D; Spill F
Bull Math Biol; 2024 Aug; 86(10):124. PubMed ID: 39207627
[TBL] [Abstract] [Full Text] [Related]
6. Cytotoxic Activity of
Gallegos-Saucedo R; Barrios-García T; Valdez-Morales EE; Cabañas-García E; Barajas-Espinosa A; Gómez-Aguirre YA; Guerrero-Alba R
Molecules; 2024 Aug; 29(16):. PubMed ID: 39202999
[TBL] [Abstract] [Full Text] [Related]
7. A CLRN3-Based CD8
Gong Z; Huang X; Cao Q; Wu Y; Zhang Q
Biomolecules; 2024 Jul; 14(8):. PubMed ID: 39199281
[TBL] [Abstract] [Full Text] [Related]
8. PIK3CA Mutated colorectal cancers Without KRAS, NRAS and BRAF Mutations Possess Common and Potentially Targetable Mutations in Epigenetic Modifiers and DNA Damage Response Genes.
Voutsadakis IA
Cancer Genomics Proteomics; 2024; 21(5):533-548. PubMed ID: 39191495
[TBL] [Abstract] [Full Text] [Related]
9. The Clinical and Genetic Landscape of Hereditary cancer: Experience from a Single Clinical Diagnostic Laboratory.
Tsoulos N; Agiannitopoulos K; Potska K; Katseli A; Ntogka C; Pepe G; Bouzarelou D; Papathanasiou A; Grigoriadis D; Tsaousis GN; Gogas H; Troupis T; Papazisis K; Natsiopoulos I; Venizelos V; Amarantidis K; Giassas S; Papadimitriou C; Fountzilas E; Stathoulopoulou M; Koumarianou A; Xepapadakis G; Blidaru A; Zob D; Voinea O; Özdoğan M; Ergören MÇ; Hegmane A; Papadopoulou E; Nasioulas G; Markopoulos C
Cancer Genomics Proteomics; 2024; 21(5):448-463. PubMed ID: 39191493
[TBL] [Abstract] [Full Text] [Related]
10. TROP2 in colorectal carcinoma: associations with histopathology, molecular phenotype, and patient prognosis.
Foersch S; Schmitt M; Litmeyer AS; Tschurtschenthaler M; Gress T; Bartsch DK; Pfarr N; Steiger K; Denkert C; Jesinghaus M
J Pathol Clin Res; 2024 Sep; 10(5):e12394. PubMed ID: 39177576
[TBL] [Abstract] [Full Text] [Related]
11. Bioinformatic analysis of the molecular targets of curcumin in colorectal cancer.
Mahmoudi A; Jamialahmadi T; Kesharwani P; Sahebkar A
Pathol Res Pract; 2024 Oct; 262():155533. PubMed ID: 39173464
[TBL] [Abstract] [Full Text] [Related]
12. The modification role and tumor association with a methyltransferase: KMT2C.
Jiao Y; Lv Y; Liu M; Liu Y; Han M; Xiong X; Zhou H; Zhong J; Kang X; Su W
Front Immunol; 2024; 15():1444923. PubMed ID: 39165358
[TBL] [Abstract] [Full Text] [Related]
13. Urachal and Nonurachal Adenocarcinomas of the Urinary Bladder: A Comprehensive Genomic Profiling Study.
Cigliola A; Basnet A; Jacob JM; Mercinelli C; Tateo V; Patanè DA; Bratslavsky G; Cheng L; Grivas P; Kamat AM; Spiess PE; Pavlick DC; Lin DI; Ross JS; Necchi A
JCO Precis Oncol; 2024 Aug; 8():e2400200. PubMed ID: 39151108
[TBL] [Abstract] [Full Text] [Related]
14. An In Vivo Metastasis Model Using Genotype-Defined Tumor Organoids.
Morita A; Nakayama M; Oshima H; Oshima M
Methods Mol Biol; 2024; 2828():57-68. PubMed ID: 39147970
[TBL] [Abstract] [Full Text] [Related]
15. The immunomodulatory effects of cannabidiol on Hsp70-activated NK cells and tumor target cells.
Wang F; Bashiri Dezfouli A; Multhoff G
Mol Immunol; 2024 Oct; 174():1-10. PubMed ID: 39126837
[TBL] [Abstract] [Full Text] [Related]
16. miR-29a expression negatively correlates with Bcl-2 levels in colorectal cancer and is correlated with better prognosis.
Raonić J; Ždralević M; Vučković L; Šunjević M; Todorović V; Vukmirović F; Marzano F; Tullo A; Giannattasio S; Radunović M
Pathol Res Pract; 2024 Oct; 262():155491. PubMed ID: 39126835
[TBL] [Abstract] [Full Text] [Related]
17. Hereditary colorectal cancer and Polyposis Syndromes Caused by Variants in Uncommon Genes.
Bouras A; Fabre A; Zattara H; Handallou S; Desseigne F; Kientz C; Prieur F; Peysselon M; Legrand C; Calavas L; Saurin JC; Wang Q
Genes Chromosomes Cancer; 2024 Aug; 63(8):e23263. PubMed ID: 39120161
[TBL] [Abstract] [Full Text] [Related]
18. Exploration of bacterial lipopolysaccharide-related genes signature based on T cells for predicting prognosis in colorectal cancer.
Cao L; Ba Y; Chen F; Zhang S; Zhang H
Aging (Albany NY); 2024 Aug; 16(15):11606-11625. PubMed ID: 39115879
[TBL] [Abstract] [Full Text] [Related]
19. Antitumorigenic potential of Lactobacillus-derived extracellular vesicles: p53 succinylation and glycolytic reprogramming in intestinal epithelial cells via SIRT5 modulation.
Zhang J; Huang X; Zhang T; Gu C; Zuo W; Fu L; Dong Y; Liu H
Cell Biol Toxicol; 2024 Aug; 40(1):66. PubMed ID: 39110260
[TBL] [Abstract] [Full Text] [Related]
20. Prevalence of KRAS amplification in patients with metastatic cancer: Real-world next-generation sequencing analysis.
Choi DH; Jang HL; Lim SH; Kim ST; Hong JY; Park SH; Park JO; Kim DG; Kim KM; Lee J
Pathol Res Pract; 2024 Sep; 261():155473. PubMed ID: 39106591
[TBL] [Abstract] [Full Text] [Related]
[Next]
